Micro-X Limited (ASX:MX1)
0.0170
+0.0030 (21.43%)
Sep 17, 2026, 3:55 PM AEST
Micro-X Revenue
In the fiscal year ending June 30, 2026, Micro-X had annual revenue of 15.09M AUD with 15.58% growth. Micro-X had revenue of 3.84M in the half year ending June 30, 2026, a decrease of -42.88%.
Revenue
15.09M
Revenue Growth
+15.58%
P/S Ratio
0.70
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.53M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 15.09M | 2.03M | 15.58% |
| Jun 30, 2025 | 13.05M | -2.17M | -14.25% |
| Jun 30, 2024 | 15.22M | 217.00K | 1.45% |
| Jun 30, 2023 | 15.01M | 6.04M | 67.28% |
| Jun 30, 2022 | 8.97M | 5.20M | 137.87% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 34.87M |
| CleanSpace Holdings | 19.82M |
| ImpediMed | 14.61M |
| CurveBeam AI | 8.67M |
| CONNEQT Health | 7.96M |
| Atomo Diagnostics | 5.33M |
| OncoSil Medical | 5.09M |
| Control Bionics | 4.77M |